Drug Shortage Report for BOOSTRIX

Last updated on 2023-05-16 History
Report ID 179831
Drug Identification Number 02247600
Brand name BOOSTRIX
Common or Proper name Combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine for booster vaccination
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID TETANUS TOXOID DIPHTHERIA TOXOID
Strength(s) 2.5MCG 8MCG 8MCG 20UNIT 2UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10s
ATC code J07AX
ATC description BACTERIAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-01-03
Estimated end date 2023-05-16
Actual end date 2023-05-15
Shortage status Resolved
Updated date 2023-05-16
Company comments Supply unavailable
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-01-04 English Compare
v2 2023-01-04 French Compare
v3 2023-03-23 English Compare
v4 2023-03-23 French Compare
v5 2023-05-10 English Compare
v6 2023-05-10 French Compare
v7 2023-05-16 English Compare
v8 2023-05-16 French Compare

Showing 1 to 8 of 8